Bibliographies thématiques / Attention-deficit-disordered adults Attention-deficit hyperactivity disorder / Articles de revues
Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Attention-deficit-disordered adults Attention-deficit hyperactivity disorder.

Articles de revues sur le sujet « Attention-deficit-disordered adults Attention-deficit hyperactivity disorder »

Auteur : Grafiati
Publié le 4 juin 2021
Mis à jour le 6 février 2022

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Attention-deficit-disordered adults Attention-deficit hyperactivity disorder ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.

1

Magon, Rakesh. « Attention-deficit hyperactivity disorder in adults ». InnovAiT : Education and inspiration for general practice 10, no 3 (26 septembre 2016) : 165–72. http://dx.doi.org/10.1177/1755738016642792.

Texte intégral
Résumé :
Attention-deficit hyperactivity disorder (ADHD) is one of the most-common psychiatric disorders; it is highly comorbid with many other psychiatric disorders and associated with substantial role impairment. Untreated ADHD results in psychiatric comorbidity, relationship and parenting problems, underachievement, frequent job losses, and opportunistic delinquency. Nevertheless, ADHD remains the most under-recognised and undertreated mental health condition in adults. This article discusses the clinical presentation of ADHD in adulthood with a particular focus on recognition, assessment and management of ADHD in adults in primary care.
Styles APA, Harvard, Vancouver, ISO, etc.
2

Janakiraman, Raguraman, et Tony Benning. « Attention-deficit hyperactivity disorder in adults ». Advances in Psychiatric Treatment 16, no 2 (mars 2010) : 96–104. http://dx.doi.org/10.1192/apt.bp.107.003848.

Texte intégral
Résumé :
SummaryAttention-deficit hyperactivity disorder (ADHD) is an established diagnosis in children but there is a lack of agreement about its validity as a distinct entity in adults. Literature suggests that between one-third and two-thirds of children diagnosed with ADHD continue to manifest symptoms into adulthood. An adult diagnosis should be done on the basis of a thorough assessment, structured and semi-structured clinical interview, and with a complete understanding of the symptoms that manifest in adults. This may be supplemented by the use of rating scales. We present a review of the literature covering aetiology, clinical presentations, diagnostic evaluation and management of ADHD in adults.
Styles APA, Harvard, Vancouver, ISO, etc.
3

SACHDEV, PERMINDER. « Attention deficit hyperactivity disorder in adults ». Psychological Medicine 29, no 3 (mai 1999) : 507–14. http://dx.doi.org/10.1017/s003329179800720x.

Texte intégral
Résumé :
Adults with putative attention deficit hyperactivity disorder (ADHD) are increasingly being referred to psychiatric clinics, often following a self-diagnosis, and demanding a prescription for stimulant medication. This has disconcerted many clinicians and started a debate on the appropriateness of this diagnosis in adults (Shaffer, 1994; Lomas, 1995; Diller, 1996) that is reminiscent of the controversies of the childhood diagnosis in previous years (Lancet, 1986). At issue is not only concern about the widespread use of stimulant medication, but also a neurobiological understanding of impulsivity, hyperactivity and antisocial behaviour and the genesis of some psychiatric disorders in adults. How is the validity of this disorder in adults then to be established?
Styles APA, Harvard, Vancouver, ISO, etc.
4

Faraone, Stephen V. « Attention Deficit Hyperactivity Disorder in Adults ». Current Directions in Psychological Science 9, no 1 (février 2000) : 33–36. http://dx.doi.org/10.1111/1467-8721.00055.

Texte intégral
Résumé :
The diagnosis of attention deficit hyperactivity disorder (ADHD) in adults has been a source of controversy, with some prominent researchers questioning its very existence and others suggesting it is an urgent clinical problem. This article reviews five domains of data addressing the validity of adult ADHD: clinical correlates, family history, treatment response, laboratory studies, and long-term outcome. It then shows how the debate over adult ADHD reflects a clash of theoretical paradigms and concludes by suggesting ways in which psychological science can collect the data needed to clarify the validity of adult ADHD.
Styles APA, Harvard, Vancouver, ISO, etc.
5

Toone, Brian, Maria Clarke et Susan Young. « Attention-deficit hyperactivity disorder in adults ». Advances in Psychiatric Treatment 5, no 2 (mars 1999) : 112–19. http://dx.doi.org/10.1192/apt.5.2.112.

Texte intégral
Résumé :
Attention-deficit hyperactivity disorder (ADHD) and hyperkinetic disorder are well-established diagnoses in children, with estimates of prevalence in pre-adolescent children from 3 to 5%. Until recently ADHD was not thought to persist beyond adolescence, but results from long-term prospective outcome studies indicate that 30–70% of children with ADHD exhibit some symptoms as adults. Recognition of this disorder is important as the persistence of ADHD symptoms has been shown to be associated with academic and occupational failure and high rates of psychiatric comorbidity. With the establishment of a UK support group (LADDER) and increasing media attention highlighting this problem it is likely that there will be an increased demand for psychiatric assessment of adult ADHD in the next few years.
Styles APA, Harvard, Vancouver, ISO, etc.
6

Rösler, Michael, Miguel Casas, Eric Konofal et Jan Buitelaar. « Attention deficit hyperactivity disorder in adults ». World Journal of Biological Psychiatry 11, no 5 (3 juin 2010) : 684–98. http://dx.doi.org/10.3109/15622975.2010.483249.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Wender, Paul H. « ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS ». Psychiatric Clinics of North America 21, no 4 (décembre 1998) : 761–74. http://dx.doi.org/10.1016/s0193-953x(05)70039-3.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Feifel, David. « Attention-deficit hyperactivity disorder in adults ». Postgraduate Medicine 100, no 3 (septembre 1996) : 207–18. http://dx.doi.org/10.3810/pgm.1996.09.78.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Moss, Shannon B., Rajasree Nair, Anthony Vallarino et Scott Wang. « Attention Deficit/Hyperactivity Disorder in Adults ». Primary Care : Clinics in Office Practice 34, no 3 (septembre 2007) : 445–73. http://dx.doi.org/10.1016/j.pop.2007.05.005.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Gutman, Sharon A., et Margery Szczepanski. « Adults with Attention Deficit Hyperactivity Disorder ». Occupational Therapy in Mental Health 21, no 2 (17 mars 2005) : 13–38. http://dx.doi.org/10.1300/j004v21n02_02.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
11

ELLIOTT, HAL. « Attention Deficit Hyperactivity Disorder in Adults ». Southern Medical Journal 95, no 7 (juillet 2002) : 736–42. http://dx.doi.org/10.1097/00007611-200295070-00015.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
12

Cubbin, S., et A. Leahy. « Attention deficit hyperactivity disorder in adults ». British Journal of Psychiatry 172, no 4 (avril 1998) : 366. http://dx.doi.org/10.1192/bjp.172.4.366b.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
13

Faraone, Stephen V., Thomas J. Spencer, C. Brendan Montano et Joseph Biederman. « Attention-Deficit/Hyperactivity Disorder in Adults ». Archives of Internal Medicine 164, no 11 (14 juin 2004) : 1221. http://dx.doi.org/10.1001/archinte.164.11.1221.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
14

Gadow, Kenneth D., et Margaret Weiss. « Attention-Deficit/Hyperactivity Disorder in Adults ». Archives of General Psychiatry 58, no 8 (1 août 2001) : 784. http://dx.doi.org/10.1001/archpsyc.58.8.784.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
15

Wilens, Timothy E. « Attention-Deficit/Hyperactivity Disorder in Adults ». JAMA 292, no 5 (4 août 2004) : 619. http://dx.doi.org/10.1001/jama.292.5.619.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
16

Pitts, Mark. « Attention deficit hyperactivity disorder in adults ». Nurse Prescribing 12, no 1 (janvier 2014) : 18–24. http://dx.doi.org/10.12968/npre.2014.12.1.18.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
17

Schreiber, Thomas J. « Attention‐Deficit Hyperactivity Disorder in Adults ». Journal of the American Academy of Child & ; Adolescent Psychiatry 37, no 7 (juillet 1998) : 791–92. http://dx.doi.org/10.1097/00004583-199807000-00021.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
18

Kapitány-Fövény, Máté. « Attention-deficit hyperactivity disorder (ADHD) in adults ». Journal of Behavioral Addictions 3, no 4 (décembre 2014) : 266–67. http://dx.doi.org/10.1556/jba.3.2014.4.8.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
19

Stein, Mark A. « Attention-Deficit Hyperactivity Disorder in Adults (Book) ». Journal of Personality Assessment 67, no 1 (août 1996) : 215–18. http://dx.doi.org/10.1207/s15327752jpa6701_18.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
20

Pieroth, Elizabeth M. « Diagnosing Attention-Deficit/Hyperactivity Disorder in Adults ». Professional Case Management 13, no 3 (mai 2008) : 179–81. http://dx.doi.org/10.1097/01.pcama.0000319975.47896.76.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
21

Zwi, Morris, et Ann York. « Attention-deficit hyperactivity disorder in adults : validity unknown1 ». Advances in Psychiatric Treatment 10, no 4 (juillet 2004) : 248–56. http://dx.doi.org/10.1192/apt.10.4.248.

Texte intégral
Résumé :
Attention-deficit hyperactivity disorder (ADHD) is a commonly diagnosed childhood psychiatric disorder. Debate over its diagnostic validity, aetiology, presentation and treatment has extended from the clinical to the public domain. As children with ADHD diagnoses reach adulthood there is increasing interest in ‘adult ADHD’. Cohorts followed up show poorer outcomes as adults than do controls. Self-referred adults, sometimes relatives of children with ADHD, are also of interest regarding adult ADHD. Innovative work is being done examining issues of aetiology, treatment, outcomes and comorbidity in these groups, but heterogeneity among those diagnosed with ADHD and changes in classification systems and diagnostic criteria over time complicate comparison of research findings. The diagnostic validity of adult ADHD remains uncertain and needs further study.
Styles APA, Harvard, Vancouver, ISO, etc.
22

Nazar, Bruno Palazzo, Camilla Moreira de Sousa Pinna, Gabriel Coutinho, Daniel Segenreich, Monica Duchesne, José Carlos Appolinario et Paulo Mattos. « Review of literature of attention-deficit/hyperactivity disorder with comorbid eating disorders ». Revista Brasileira de Psiquiatria 30, no 4 (décembre 2008) : 384–89. http://dx.doi.org/10.1590/s1516-44462008000400014.

Texte intégral
Résumé :
OBJECTIVE: According to studies of prevalence, up to 70% of adults with attention deficit/hyperactivity disorder have at least one psychiatric comorbidity, which leads to diagnostic and therapeutic difficulties as well as more severe functional impairment. There is a paucity of data on the comorbidity of attention deficit/hyperactivity disorder and eating disorders. The objective of this study was to review the literature regarding the attention deficit/hyperactivity disorder/eating disorders comorbidity, performing a critical analysis of relevant data. METHOD: Articles in Medline, Lilacs, SciELO, ISI and PsycINFO databases from 1980 up to 2008, were searched. The references from the articles were used as additional sources of data. RESULTS: Fourteen articles were found: five prevalence studies, four case reports, three case-control studies, one symptom-assessment study of attention deficit/hyperactivity disorder and eating disorders, and one article regarding possible causes of the association between attention deficit/hyperactivity disorder and eating disorders. These articles suggested that adult women with attention deficit/hyperactivity disorder are at higher risk of developing eating disorders, especially bulimia nervosa. Bulimia Nervosa rates found in attention deficit/hyperactivity disorder groups ranged from 1% to 12%, versus 0% to 2% in control groups. CONCLUSIONS: Although there seems to be a relationship between attention deficit/hyperactivity disorder and eating disorders, the reduced number of studies available, with various methodologies, and small sample sizes limit the generalization of the findings.
Styles APA, Harvard, Vancouver, ISO, etc.
23

MANCINI, C., M. VAN AMERINGEN, J. M. OAKMAN et D. FIGUEIREDO. « Childhood attention deficit/hyperactivity disorder in adults with anxiety disorders ». Psychological Medicine 29, no 3 (mai 1999) : 515–25. http://dx.doi.org/10.1017/s0033291798007697.

Texte intégral
Résumé :
Background. Previous research has reported co-morbidity between attention deficit hyperactivity disorder (ADHD) and anxiety disorders. Interpretation of these findings is complicated by symptom overlap in the clinical presentation of the disorders. We estimate the prevalence of ADHD in both the current and childhood histories of adults with anxiety disorders, while taking symptom overlap into account. We also evaluate the utility of the Wender Utah Rating Scale (WURS) for retrospective reporting of ADHD.Methods. Consecutive admissions (N=149) to an anxiety disorders clinic were given a diagnostic and psychometric assessment. The WURS was administered to obtain a retrospective diagnosis of childhood ADHD. Twenty-nine of the 35 people surpassing the cut-off score on the WURS were given a structured interview of adult ADHD symptoms.Results. The WURS contains many ‘internalizing’ items that may inflate retrospective accounts of ADHD. After taking this into account, there is still a significantly higher prevalence of ADHD in the retrospective reports of adults with anxiety disorders (15%) than would be expected by chance (4%). Furthermore, of those who meet retrospective criteria for ADHD, 45% (13 of 29) continue to meet diagnostic criteria for ADHD as adults.Conclusions. The WURS may require considerable revision for use with clinical populations. In spite of these difficulties with retrospective assessment, available evidence indicates that ADHD is more prevalent in the histories of anxiety disordered patients than would be expected from base rates.
Styles APA, Harvard, Vancouver, ISO, etc.
24

Freire Lucas, R. M. « Late onset adult attention deficit hyperactivity disorder ». European Psychiatry 26, S2 (mars 2011) : 1718. http://dx.doi.org/10.1016/s0924-9338(11)73422-8.

Texte intégral
Résumé :
Attention-deficit hyperactivity disorder (ADHD) is a common, genetically transmitted neurological disorder, with onset in childhood, probably mediated in part by decreased brain dopaminergic functioning. Prevalence and natural history data suggest that of the 3–10% of children diagnosed with ADHD, one-to two-thirds continue to manifest appreciable ADHD symptoms as adults, interfering in academic, professional, affective and social life. Recently, several studies have challenged DSM-IV's requirement of ADHD onset before age 7 with the questioning of the validity of the age-at onset criterion.Based on the description of a late onset ADHD clinical case (onset after the age of 7), this presentation shows a review on the recent literature about ADHD, addressing how ADHD in adults can be readily diagnosed and treated using the Wender Utah diagnostic criteria to identify adult characteristics of the disorder. This work also addresses core hypotheses of etiology and treatment. The study was based on a revision of articles from Medline/PubMed, PsycINFO and from books published in the last years.
Styles APA, Harvard, Vancouver, ISO, etc.
25

Gleason, Andrew, et David Castle. « Adult attention-deficit hyperactivity disorder and bipolar disorder ». Advances in Psychiatric Treatment 18, no 3 (mai 2012) : 198–204. http://dx.doi.org/10.1192/apt.bp.110.008508.

Texte intégral
Résumé :
SummaryIncreasing attention is being paid to the concept of attention-deficit hyperactivity disorder (ADHD) in adults, in concord with evidence that suggests a proportion of children with ADHD continue to manifest symptoms into adulthood. Attention-deficit hyperactivity disorder has some symptoms in common with hypomania, and can co-occur with bipolar disorder. The diagnosis and management of ADHD in adults with bipolar disorder can be complicated, owing to challenges resulting from symptom overlap, questions of diagnostic validity and a paucity of empirical evidence to guide treatment. This article addresses comorbid ADHD and bipolar disorder, and provides practical suggestions for diagnosis and management.
Styles APA, Harvard, Vancouver, ISO, etc.
26

Kuan, A. J., et A. H. Young. « Attention-deficit hyperactivity disorder and mood disorders in adults ». British Journal of Psychiatry 191, no 2 (août 2007) : 181–82. http://dx.doi.org/10.1192/bjp.191.2.181a.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
27

Sable, Jeffrey J., Kristin L. Knopf, Marie R. Kyle, Lauren T. Schully, Megan M. Brooks, Kelly H. Parry, Ivy A. Thompson et al. « Attention-deficit hyperactivity disorder reduces automatic attention in young adults ». Psychophysiology 50, no 3 (14 janvier 2013) : 308–13. http://dx.doi.org/10.1111/psyp.12012.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
28

Victor, Marcelo M., Bruna S. da Silva, Djenifer B. Kappel, Claiton HD Bau et Eugenio H. Grevet. « Attention-deficit hyperactivity disorder in ancient Greece : The Obtuse Man of Theophrastus ». Australian & ; New Zealand Journal of Psychiatry 52, no 6 (26 avril 2018) : 509–13. http://dx.doi.org/10.1177/0004867418769743.

Texte intégral
Résumé :
We present an ancient Greek description written by the philosopher Theophrastus in his classic book ‘ Characters’ comparable with modern attention-deficit hyperactivity disorder. The arguments are based in one chapter of this book—The Obtuse Man—presenting features of a character closely resembling the modern description of attention-deficit hyperactivity disorder. In a free comparative exercise, we compared Theophrastus descriptions with modern Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5) attention-deficit hyperactivity disorder symptoms. The sentences describing The Obtuse Man written by Theophrastus are similar to several symptoms of attention-deficit hyperactivity disorder and he would probably be currently diagnosed with this disorder as an adult. To our knowledge, this is the oldest description compatible with the current conception of attention-deficit hyperactivity disorder in adults in the Western literature. Differently than the moralistic view of ancient Greece regarding those symptoms, the medical attention-deficit hyperactivity disorder conception may be advantageous to patients since it might reduce prejudice and allow individuals to seek treatment.
Styles APA, Harvard, Vancouver, ISO, etc.
29

Pliszka, Steven, William W. Dodson et Thomas J. Spencer. « Current Treatments of Attention-Deficit/Hyperactivity Disorder ». CNS Spectrums 5, S3 (mai 2000) : s1—s8. http://dx.doi.org/10.1017/s1092852900023634.

Texte intégral
Résumé :
ABSTRACTAttention-deficit/hyperactivity disorder (ADHD) is a genetic disorder that affects both children and adults. Genetic studies have shown the heritability of ADHD to be higher than other psychiatric disorders. In addition, imaging studies have revealed various structural anomalies in the brain.Often ADHD persists into adulthood. The presentation of ADHD into adulthood most often results from childhood onset of ADHD. Symptoms of inattention and functional behavior tend to persist. These symptoms may often be less obvious, with less overt hyperactivity and impulsiveness.Stimulant medications remain the predominant choice for the treatment of ADHD. They are safe and offer good response. Common adverse reactions can usually be removed by changing the dose and the timing of medication administration. Of the second-line agents for treating ADHD, the tricyclic antidepressants have generated the most studies and have proved fairly efficacious.
Styles APA, Harvard, Vancouver, ISO, etc.
30

Kentrou, Vasiliki, Danielle MJ de Veld, Kawita JK Mataw et Sander Begeer. « Delayed autism spectrum disorder recognition in children and adolescents previously diagnosed with attention-deficit/hyperactivity disorder ». Autism 23, no 4 (24 septembre 2018) : 1065–72. http://dx.doi.org/10.1177/1362361318785171.

Texte intégral
Résumé :
Phenotypic elements of autism spectrum disorder can be masked by attention-deficit/hyperactivity disorder symptoms, potentially leading to a misdiagnosis or delaying an autism spectrum disorder diagnosis. This study explored differences in the age of autism spectrum disorder diagnosis between participants with previously diagnosed attention-deficit/hyperactivity disorder versus autism spectrum disorder–only respondents. Children and adolescents, but not adults, initially diagnosed with attention-deficit/hyperactivity disorder received an autism spectrum disorder diagnosis an average of 1.8 years later than autism spectrum disorder–only children, although the findings regarding the adult sample should be interpreted with caution. Gender differences were also explored, revealing that the delay in receiving an autism diagnosis was 1.5 years in boys and 2.6 years in girls with pre-existing attention-deficit/hyperactivity disorder, compared with boys and girls without prior attention-deficit/hyperactivity disorder. No significant gender differences were observed in the adult sample. We argue that overlapping symptoms between autism spectrum disorder and attention-deficit/hyperactivity disorder might delay a formal diagnosis of autism either by leading to a misdiagnosis of attention-deficit/hyperactivity disorder or by making it difficult to identify the presence of co-occurring autism spectrum disorder conditions once an initial diagnosis of attention-deficit/hyperactivity disorder has been obtained. Current findings highlight the need to recruit multidimensional and multidisciplinary screening procedures to assess for potential emerging autism spectrum disorder hallmarks in children and adolescents diagnosed or presenting with attention-deficit/hyperactivity disorder symptoms.
Styles APA, Harvard, Vancouver, ISO, etc.
31

Janssens, Astrid, Helen Eke, Anna Price, Tamsin Newlove-Delgado, Sharon Blake, Cornelius Ani, Philip Asherson et al. « The transition from children’s services to adult services for young people with attention deficit hyperactivity disorder : the CATCh-uS mixed-methods study ». Health Services and Delivery Research 8, no 42 (novembre 2020) : 1–154. http://dx.doi.org/10.3310/hsdr08420.

Texte intégral
Résumé :
Background Attention deficit hyperactivity disorder was previously seen as a childhood developmental disorder, so adult mental health services were not set up to support attention deficit hyperactivity disorder patients who became too old for child services. To our knowledge, this is the first in-depth study of the transition of attention deficit hyperactivity disorder patients from child to adult health services in the UK. Objectives Our objectives were to explore how many young people with attention deficit hyperactivity disorder are in need of services as an adult, what adult attention deficit hyperactivity disorder services are available and how attention deficit hyperactivity disorder stakeholders experience transition from child to adult services. Design An interactive mixed-method design was adopted with three study streams: (1) a 12-month surveillance study with 9-month follow-up to find out how many young people required ongoing medication when they were too old for child services (929 surveys completed by children’s clinicians); (2) a mapping study to identify and describe services for young adults with attention deficit hyperactivity disorder (2686 respondents to online surveys for patients and health workers and freedom of information requests to service providers and commissioners); and (3) a qualitative study to explore key stakeholders’ experiences of transition from child to adult services (144 interviews with 64 attention deficit hyperactivity disorder patients, 28 parents and 52 health clinicians; 38 working in child or adult secondary health services and 14 general practitioners). Members of the public advised at each stage of the study. Results When corrected for non-response and case ascertainment, the annual number of young people with an ongoing need for medication for attention deficit hyperactivity disorder lies between 270 and 599 per 100,000 people aged 17–19 years. Among 315 individuals eligible for transition, 64% were accepted, but only 22% attended their first adult services appointment. Our interactive map describes 294 unique services for adults with attention deficit hyperactivity disorder across the UK, of which 44 are ‘dedicated’ attention deficit hyperactivity disorder services. Few services provide the full range of recommended provision; most focus on diagnosis and medication. Services are unevenly distributed across the UK, with nearly all ‘dedicated’ services being in England. Exploring stakeholders’ experiences revealed how invested the stakeholders are in continuing attention deficit hyperactivity disorder treatment and how the architecture of services affects transition. An association between attention deficit hyperactivity disorder, education and continuance of medication into young adulthood, plus parent involvement and feeling prepared for transition and adult life with attention deficit hyperactivity disorder, influenced investment. However, even with investment, how accessible adult services are, how patient needs fit with the remit of the adult service and the level of patient information available affect transition outcomes. The results also highlight how general practitioners can end up as care co-ordinators during transition by default. Limitations Transition estimates were based on those who want medication, so these indicate a minimum level of need. Conclusions Few of those who need ongoing support for attention deficit hyperactivity disorder successfully transfer to adult services, and a small proportion of those who transfer experience optimal transitional care. Adult attention deficit hyperactivity disorder service provision is patchy. Even among ‘dedicated’ services, few provide the whole range of National Institute for Health and Care Excellence-recommended treatments. Future work We need to evaluate various models of transitional care and adult attention deficit hyperactivity disorder provision, as well as develop and evaluate psychosocial interventions for young people and adults with attention deficit hyperactivity disorder. Trial registration Current Controlled Trials ISRCTN12492022. Funding This project was funded by the National Institute for Health Research (NIHR) Health Services and Delivery Research programme and will be published in full in Health Services and Delivery Research; Vol. 8, No. 42. See the NIHR Journals Library website for further project information.
Styles APA, Harvard, Vancouver, ISO, etc.
32

Toone, B. K., et G. J. H. Van Der Linden. « Attention deficit hyperactivity disorder or hyperkinetic disorder in adults ». British Journal of Psychiatry 170, no 6 (juin 1997) : 489–91. http://dx.doi.org/10.1192/bjp.170.6.489.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
33

Greenfield, Brain, et Lily Hechman. « Treatment of attention deficit hyperactivity disorder in adults ». Expert Review of Neurotherapeutics 5, no 1 (janvier 2005) : 107–21. http://dx.doi.org/10.1586/14737175.5.1.107.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
34

Wilens, Timothy E., Joseph Biederman et Thomas J. Spencer. « Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Adults ». CNS Drugs 9, no 5 (1998) : 347–56. http://dx.doi.org/10.2165/00023210-199809050-00002.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
35

Rief, Winfried. « Neurofeedback in adults with attention-deficit hyperactivity disorder ». Lancet Psychiatry 4, no 9 (septembre 2017) : 650–51. http://dx.doi.org/10.1016/s2215-0366(17)30314-0.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
36

Faraone, Stephen V., Joseph Biederman, Thomas Spencer, Tim Wilens, Larry J. Seidman, Eric Mick et Alysa E. Doyle. « Attention-deficit/hyperactivity disorder in adults : an overview ». Biological Psychiatry 48, no 1 (juillet 2000) : 9–20. http://dx.doi.org/10.1016/s0006-3223(00)00889-1.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
37

WEISS, MARGARET, CANDICE MURRAY et GABRIELLE WEISS. « Adults with Attention-Deficit/Hyperactivity Disorder : Current Concepts ». Journal of Psychiatric Practice 8, no 2 (mars 2002) : 99–111. http://dx.doi.org/10.1097/00131746-200203000-00006.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
38

Cumyn, Lucy, Lisa French et Lily Hechtman. « Comorbidity in Adults with Attention-Deficit Hyperactivity Disorder ». Canadian Journal of Psychiatry 54, no 10 (octobre 2009) : 673–83. http://dx.doi.org/10.1177/070674370905401004.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
39

Ashjazadeh, Nahid, Ali Sahraeian, Iman Sabzgolin et Ali A. Asadi-Pooya. « Attention-deficit hyperactivity disorder in adults with epilepsy ». Epilepsy & ; Behavior 101 (décembre 2019) : 106543. http://dx.doi.org/10.1016/j.yebeh.2019.106543.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
40

Brikell, Isabell, Ralf Kuja-Halkola et Henrik Larsson. « Heritability of attention-deficit hyperactivity disorder in adults ». American Journal of Medical Genetics Part B : Neuropsychiatric Genetics 168, no 6 (30 juin 2015) : 406–13. http://dx.doi.org/10.1002/ajmg.b.32335.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
41

Newcorn, Jeffrey H. « Bupropion for adults with attention deficit hyperactivity disorder ». Current Psychiatry Reports 4, no 2 (avril 2002) : 86–87. http://dx.doi.org/10.1007/s11920-002-0039-0.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
42

MARKS, DAVID J., JEFFREY H. NEWCORN et JEFFREY M. HALPERIN. « Comorbidity in Adults with Attention-Deficit/Hyperactivity Disorder ». Annals of the New York Academy of Sciences 931, no 1 (25 janvier 2006) : 216–38. http://dx.doi.org/10.1111/j.1749-6632.2001.tb05781.x.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
43

Ossmann, Janet M., et Neil W. Mulligan. « Inhibition and Attention Deficit Hyperactivity Disorder in Adults ». American Journal of Psychology 116, no 1 (2003) : 35. http://dx.doi.org/10.2307/1423334.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
44

Clarke, Adam R., Robert J. Barry, Patrick C. L. Heaven, Rory McCarthy, Mark Selikowitz et Mitchell K. Byrne. « EEG in adults with Attention-Deficit/Hyperactivity Disorder ». International Journal of Psychophysiology 70, no 3 (décembre 2008) : 176–83. http://dx.doi.org/10.1016/j.ijpsycho.2008.07.001.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
45

Hesslinger, Bernd, Ludger Tebartz van Elst, Elisabeth Nyberg, Petra Dykierek, Harald Richter, Michael Berner et Dieter Ebert. « Psychotherapy of attention deficit hyperactivity disorder in adults ». European Archives of Psychiatry and Clinical Neuroscience 252, no 4 (août 2002) : 177–84. http://dx.doi.org/10.1007/s00406-002-0379-0.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
46

Johnson, Joe, Sarah Morris et Sanju George. « Attention deficit hyperactivity disorder in adults : what the non-specialist needs to know ». British Journal of Hospital Medicine 81, no 3 (2 mars 2020) : 1–11. http://dx.doi.org/10.12968/hmed.2019.0188.

Texte intégral
Résumé :
Attention deficit hyperactivity disorder is a persistent, pervasive neurodevelopmental disorder, characterised by the core features of hyperactivity, impulsivity and inattention. While previously thought to be a condition that only affects children, it is now well recognised that in a significant proportion of cases both symptoms and associated impairment will persist into adulthood. Nevertheless, many cases are missed or misdiagnosed because of the lack of awareness of attention deficit hyperactivity disorder as a potential diagnosis in adults, the number of symptoms that overlap with other psychiatric conditions, and the high rates of comorbidity. However, once correctly diagnosed, attention deficit hyperactivity disorder responds well to treatment, particularly pharmacological intervention. This article gives an overview of attention deficit hyperactivity disorder with special emphasis on the diagnosis and pharmacological treatment of attention deficit hyperactivity disorder in adults.
Styles APA, Harvard, Vancouver, ISO, etc.
47

Biederman, J., et T. Spencer. « Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder ». Journal of Attention Disorders 6, no 1_suppl (avril 2002) : 101–7. http://dx.doi.org/10.1177/070674370200601s12.

Texte intégral
Résumé :
Attention-Deficit/Hyperactivity Disorder (ADHD) can persist into adulthood with a continuation of the pattern of childhood psychopathology, cognition and functioning. Adult comorbidities include substance use disorders, antisocial personality disorder, anxiety and depression. Studies have shown that as in children, methylphenidate treatment for adults can lead to a robust, dose-dependent improvement in ADHD symptoms. Future research is needed to evaluate the safety and efficacy of long-term treatment with methylphenidate (MPH).
Styles APA, Harvard, Vancouver, ISO, etc.
48

Kweon, Kukju. « Pharmacological treatment for attention deficit hyperactivity disorder in adults ». Journal of the Korean Medical Association 64, no 1 (10 janvier 2021) : 49–56. http://dx.doi.org/10.5124/jkma.2021.64.1.49.

Texte intégral
Résumé :
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by attention deficits, hyperactivity, and impulsivity. In the past, ADHD was considered to be limited to children and adolescents. However, ADHD has now been reconceptualized as a lifelong disorder, and two-thirds of ADHD patients continue to have core symptoms and dysfunction in adulthood. Currently, the public and clinicians’ interest in adult ADHD is rapidly increasing in Korea. In addition to interviews with patients for an adult ADHD diagnosis, interviews with family members, existing school records, and neuropsychological tests help clinicians to make a diagnosis. It is necessary to check whether the core symptoms of ADHD were expressed in childhood. Since adults’ symptom patterns differ from those of children, a self-report tool designed for adult ADHD is useful. The medications currently approved for ADHD in adults by the Ministry of Food and Drug Safety of Korea are long-acting methylphenidate and atomoxetine. Both methylphenidate and atomoxetine improve the core symptoms of ADHD as well as daily function. Methylphenidate and atomoxetine can be used safely as first-line treatments, and the overall adverse effects are tolerable. However, attention should be paid to possible cardiovascular adverse events and misuse. Bupropion, modafinil, alpha2-agonist, and tricyclic antidepressants can also be used off-label.
Styles APA, Harvard, Vancouver, ISO, etc.
49

Hollingsworth, Deidre E., Sean P. McAuliffe et Barbara J. Knowlton. « Temporal Allocation of Visual Attention in Adult Attention Deficit Hyperactivity Disorder. » Journal of Cognitive Neuroscience 13, no 3 (1 avril 2001) : 298–305. http://dx.doi.org/10.1162/08989290151137359.

Texte intégral
Résumé :
In two experiments, we examined the ability of adults with attention deficit hyperactivity disorder (ADHD) to preocess multiple targets appearing in a rapid serial visual presentation (RSVP) stream. Using a standard attentional blink (AB) task, subjects were required to both identify a target in the RSVP stream and detect a probe appearing in one of several posttarget serial positions. In Experiment 1, ADHD adults exhibited a protracted AB compared to controls, in that their probe detection did not improve as a function of increasing probe-to-target intervals (450-720 msec). In Experiment 2, the ADHD group performed as well as controls in detectin probes appearing immediately (i.e., 90 msec) after the target. Taken together, the results demonstrate that adults with ADHD exhibit a selective deficit in rapidly shifting attention between the target and the probe, when two appear several hundred milliseconds apart. These results suggest that adults with ADHD can use automatic (reflexive) attention to detect items in close temporal proximity in the RSVP stream, but have difficulty allocating controlled attention to multiple stimuli separated by several hundred milliseconds.
Styles APA, Harvard, Vancouver, ISO, etc.
50

Cowles, Brian J. « Lisdexamfetamine for Treatment of Attention-Deficit/Hyperactivity Disorder ». Annals of Pharmacotherapy 43, no 4 (31 mars 2009) : 669–76. http://dx.doi.org/10.1345/aph.1l521.

Texte intégral
Résumé :
Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of the prodrug lisdexamfetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adults and describe its potential place in therapy. Data Sources: Primary literature published between January 1, 1990, and August 1, 2008, was selected from PubMed using the search key words lisdexamfetamine, Vyvanse, and NRP104. References of selected publications were also reviewed. Posters and abstracts of research presented at national meetings were reviewed when available. The product labeling for Vyvanse was also used. Study Selection and Data Extraction: Preference was given to published, randomized, and controlled research describing the pharmacokinetics, efficacy, and safety of lisdexamfetamine. Noncontrolled studies, postmarketing reports, and poster presentations were considered secondly. All published studies were included. Data Synthesis: Lisdexamfetamine is a prodrug of dextroamphetamine covatently bound to Hysine, which is activated during first-pass metabolism. The unique pharmacokinetic profile owing to lisdexamfetamine's prodrug design and rate-limited enzymatic biotransformation allows for once-daily dosing with a duration of activity of approximately 12 hours. Lisdexamfetamine has been proven to reduce the symptoms of ADHD both in children aged 6–12 years and adults aged 18–55 years, decreasing ADHD rating scale scores by approximately 27 and 19 points, respectively. Adverse effects with an incidence greater than 10% during preclinical trials included appetite suppression, insomnia, and headache. Lisdexamfetamine's unique pharmacokinetic properties may provide additional safety with regard to reducing abuse potential. As with other central nervous system (CNS) stimulants, concerns regarding sudden cardiac death and adverse effects on growth also apply to lisdexamfetamine. Conclusions: Lisdexamfetamine provides another amphetamine-based CNS stimulant option for treatment of children and adults with ADHD. However, its use may be limited by a lack of significant differentiation when compared with cunently used stimulants and a lack of evidence to support its use in adolescents.
Styles APA, Harvard, Vancouver, ISO, etc.
Vous pouvez également être intéressé par les bibliographies sur le sujet « Attention-deficit-disordered adults Attention-deficit hyperactivity disorder » pour d’autres types de sources :
Thèses Livres
Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!

Vers la bibliographie